Funded Startups in Philadelphia
Disclosed deal sizes in Philadelphia skew heavily toward one outlier: Gopuff’s $250M (Venture - Series Unknown) on 2025-11-16 is the only disclosed round a…
Disclosed deal sizes in Philadelphia skew heavily toward one outlier: Gopuff’s $250M (Venture - Series Unknown) on 2025-11-16 is the only disclosed round above $150M, dwarfing the next-largest disclosed amounts like Alterra IOS at $344M (2025-07-16) and MD Capital at $225M (2025-01-23); most other disclosed rounds fall in the single-digit millions (e.g., Sahay AI $2M on 2025-10-29; Verismo Therapeutics $4M on 2025-01-07). Temporally, the 50 rows span 2024-07-01 through 2025-11-16, with a dense late-2024 to mid-2025 cluster where multiple entries land in June–July 2024 and again May–June 2025.
Sector-wise, Healthcare/biotech-related themes recur frequently (e.g., Arya Health $18M on 2025-11-01; BlueWhale Bio $5M on 2025-10-19; Arctic Therapeutics $28M on 2025-01-21; Cabaletta Bio $100M on 2025-06-11), and the stage labeling is often non-specific: “Series Unknown” appears in many rows, while “undisclosed” amounts also show up repeatedly (e.g., Sproutr on 2025-05-15; eLuna on 2024-08-05).
Most recent rounds
50 shownRelated listings
Frequently asked
What outlier dominates Philadelphia’s disclosed-round amounts, and how does it stack up against the rest of the list?
The largest disclosed amount is Alterra IOS at $344M (2025-07-16, Venture - Series Unknown), followed by Gopuff at $250M (2025-11-16) and MD Capital at $225M (2025-01-23). Those three disclosed rounds sit far above most other disclosed entries, many of which are in the ~$1M–$28M range (e.g., Sahay AI $2M on 2025-10-29; Arctic Therapeutics $28M on 2025-01-21).
Is there a clear concentration of rounds within a narrow time window in these 50 Philadelphia entries?
Yes. Several rounds cluster in mid-year: Proscia $50M on 2025-03-19, followed by a June 2025 run including Cabaletta Bio $100M on 2025-06-11 and Brandywine Realty Trust $150M on 2025-06-17. Another concentration appears in July 2024 (e.g., Exyn Technologies $5M on 2024-07-03 and PACE AI undisclosed on 2024-07-01).
Which stage/amount-reporting patterns are common, and where do they show up in specific rows?
Non-specific stage labeling is frequent: multiple entries are marked “Series Unknown,” including Gopuff (2025-11-16) and Alterra IOS (2025-07-16). Separately, “undisclosed” amounts occur multiple times, including Sproutr (2025-05-15, undisclosed) and eLuna (2024-08-05, undisclosed), which makes disclosed-size comparisons uneven across the list.
Do any sectors appear often enough to suggest a Philadelphia-biased portfolio theme in this dataset?
Healthcare and adjacent biotech-related themes recur repeatedly. Examples include Arya Health ($18M, 2025-11-01), BlueWhale Bio ($5M, 2025-10-19), Cabaletta Bio ($100M, 2025-06-11), Verismo Therapeutics ($4M, 2025-01-07), and Arctic Therapeutics ($28M, 2025-01-21).
How do the smallest disclosed rounds compare to the typical disclosed-size range, and which entries set the floor?
The smallest disclosed amount is $20K for The Food Trust (2025-04-14, Series Unknown). Multiple other very small disclosed entries sit near the low end (e.g., Inner Strength Education $60K on 2025-01-10 and AmorSui $50K on 2024-08-27), which contrasts with much larger disclosures like Brandywine Realty Trust at $150M (2025-06-17).
What does the timeline say about the most recent versus earliest rounds shown?
The most recent row is Gopuff’s $250M on 2025-11-16. The earliest date in the 50-row window is 2024-07-01 (PACE AI, amount undisclosed), meaning the displayed activity spans roughly from July 2024 to November 2025.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.